» Articles » PMID: 33147804

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease

Abstract

The excess intake of dietary sodium is a key modifiable factor for reducing disease progression in autosomal dominant polycystic kidney disease (ADPKD). The aim of this study was to test the hypothesis that the scored salt questionnaire (SSQ; a frequency questionnaire of nine sodium-rich food types) is a valid instrument to identify high dietary salt intake in ADPKD. The performance of the SSQ was evaluated in adults with ADPKD with an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m during the screening visit of the PREVENT-ADPKD trial. High dietary sodium intake (HSI) was defined by a mean 24-h urinary sodium excretion ≥ 100 mmol/day from two collections. The median 24-h urine sodium excretion was 132 mmol/day (IQR: 112-172 mmol/d) ( = ; mean age: 44.6 ± 11.5 years old; 53% female), and HSI (86.7% of total) was associated with male gender and higher BMI and systolic blood pressure ( < 0.05). The SSQ score (73 ± 23; mean ± SD) was weakly correlated with log 24-h urine sodium excretion ( = 0.29, = 0.01). Receiving operating characteristic analysis showed that the optimal cut-off point in predicting HSI was an SSQ score of 74 (area under the curve 0.79; sensitivity 61.5%; specificity 90.0 < 0.01). The evaluation of the SSQ in participants with a BMI ≥ 25 ( = 46) improved the sensitivity (100%) and the specificity (100%). Consumers with an SSQ score ≥ 74 ( = 41) had higher relative percentage intake of processed meats/seafood and flavourings added to cooking < 0.05). In conclusion, the SSQ is a valid tool for identifying high dietary salt intake in ADPKD but its value proposition (over 24-h urinary sodium measurement) is that it may provide consumers and their healthcare providers with insight into the potential origin of sodium-rich food sources.

Citing Articles

Family Self-management Program for Hypertension Management and Sodium Consumption Adherence: A Parallel Randomized Control Trial Among Family Caregivers and People With Hypertension.

Susanto T, Hernawati S, Yunanto R, Rahmawati I, Ati N, Fauziah W J Res Health Sci. 2024; 24(4):e00628.

PMID: 39431653 PMC: 11492525. DOI: 10.34172/jrhs.2024.163.


Cardiovascular Manifestations and Management in ADPKD.

Sagar P, Rangan G Kidney Int Rep. 2023; 8(10):1924-1940.

PMID: 37850017 PMC: 10577330. DOI: 10.1016/j.ekir.2023.07.017.

References
1.
Garofalo C, Borrelli S, Provenzano M, De Stefano T, Vita C, Chiodini P . Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. Nutrients. 2018; 10(6). PMC: 6024651. DOI: 10.3390/nu10060732. View

2.
Aybal Kutlugun A, Arici M, Yildirim T, Turgut D, Yilmaz R, Altindal M . Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract. 2011; 118(4):c361-6. DOI: 10.1159/000323392. View

3.
Knuiman J, Hautvast J, Van der Heyden L, Geboers J, JOOSSENS J, Tornqvist H . A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum Nutr Clin Nutr. 1986; 40(3):229-37. View

4.
Baker P, Machado P, Santos T, Sievert K, Backholer K, Hadjikakou M . Ultra-processed foods and the nutrition transition: Global, regional and national trends, food systems transformations and political economy drivers. Obes Rev. 2020; 21(12):e13126. DOI: 10.1111/obr.13126. View

5.
Tsuchihashi T . Practical and personal education of dietary therapy in hypertensive patients. Hypertens Res. 2019; 43(1):6-12. DOI: 10.1038/s41440-019-0340-5. View